ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer.

Erica Hlavin Bell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.